- Home
- GFAI vs CRIS Comparison
GFAI vs CRIS Comparison
Compare GFAI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- CRIS
- Stock Information
- Founded
- GFAI 2018
- CRIS 2000
- Country
- GFAI Singapore
- CRIS United States
- Employees
- GFAI N/A
- CRIS N/A
- Industry
- GFAI Diversified Commercial Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GFAI Consumer Discretionary
- CRIS Health Care
- Exchange
- GFAI Nasdaq
- CRIS Nasdaq
- Market Cap
- GFAI 19.1M
- CRIS 18.6M
- IPO Year
- GFAI N/A
- CRIS 2000
- Fundamental
- Price
- GFAI $0.83
- CRIS $1.14
- Analyst Decision
- GFAI Strong Buy
- CRIS Strong Buy
- Analyst Count
- GFAI 1
- CRIS 2
- Target Price
- GFAI $4.50
- CRIS $16.50
- AVG Volume (30 Days)
- GFAI 381.2K
- CRIS 75.6K
- Earning Date
- GFAI 09-23-2025
- CRIS 11-06-2025
- Dividend Yield
- GFAI N/A
- CRIS N/A
- EPS Growth
- GFAI N/A
- CRIS N/A
- EPS
- GFAI N/A
- CRIS N/A
- Revenue
- GFAI $36,987,715.00
- CRIS $11,650,000.00
- Revenue This Year
- GFAI $5.66
- CRIS $2.72
- Revenue Next Year
- GFAI $4.69
- CRIS $8.27
- P/E Ratio
- GFAI N/A
- CRIS N/A
- Revenue Growth
- GFAI 4.38
- CRIS 13.56
- 52 Week Low
- GFAI $0.76
- CRIS $1.02
- 52 Week High
- GFAI $3.88
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- GFAI 33.59
- CRIS 20.03
- Support Level
- GFAI $0.85
- CRIS $1.21
- Resistance Level
- GFAI $0.93
- CRIS $1.35
- Average True Range (ATR)
- GFAI 0.07
- CRIS 0.09
- MACD
- GFAI -0.01
- CRIS -0.03
- Stochastic Oscillator
- GFAI 6.44
- CRIS 1.92
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.